Johnson & Johnson (JNJ)

NYSE: JNJ · Real-Time Price · USD

156.31

0.40 (0.26%)

At close: Apr 30, 2025, 3:59 PM

155.36

-0.61%

Pre-market: May 01, 2025, 08:06 AM EDT

0.26% (1D)

Bid	155.36
Market Cap	376.68B
Revenue (ttm)	89.33B
Net Income (ttm)	21.81B
EPS (ttm)	9
PE Ratio (ttm)	17.37
Forward PE	14.16
Analyst	Buy

Ask	156
Volume	5,123,559
Avg. Volume (20D)	9,711,900
Open	158.20
Previous Close	155.91
Day's Range	155.03 - 158.09
52-Week Range	140.68 - 169.99
Beta	0.48

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED co...

[Read more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Jan 2, 1943

Employees 138,100

Stock Exchange NYSE

Ticker Symbol JNJ

Website https://www.jnj.com

Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $169, which is an increase of 8.12% from the latest price.

Stock Forecasts

Why Price Moved

4 weeks ago

-7.59%

Johnson & Johnson shares are trading lower after a... Unlock content with Pro Subscription

6 months ago

+1.55%

Johnson & Johnson shares are trading higher after the company reported better-than-expected Q3 financial results.

News

1 day ago · https://247wallst.com

Warren Buffett Sees Right Through Trump’s Tariffs

24/7 Wall St. Key Points: Warren Buffett’s investment philosophy emphasizes long-term holdings in companies with strong competitive moats, such as Coca-Cola (NYSE: KO), American Express (NYSE: A...

15 hours ago · reuters.com

US FDA approves J&J's immune disorder drug

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug to treat patients aged 12 years and older with an immune-mediated disorder, the drugmaker said on Wednesday.

2 days ago · reuters.com

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are among the more than two-dozen senior business leaders slated to visit the White House on Wed...

2 days ago · seekingalpha.com

My 10 Must-Own Dividend Stocks For Your Retirement Portfolio (One Yields 9.65%)

I present 10 must-own dividend stocks for your retirement portfolio to help you blend dividend income, growth and capital appreciation, designed to anchor a well-diversified dividend portfolio. Allian...

2 days ago · businesswire.com

Johnson & Johnson to Participate in the Bernstein's 41st Annual Strategic Decisions Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bernstein's 41st Annual Strategic Decisions Conference on Wednesday, May 28th, 2025. Management will participate...

2 days ago · marketbeat.com

3 Industry Behemoths Are Rewarding Investors With Dividend Bumps

In a market where investors are increasingly seeking stability and reliable returns, several industry giants have stepped up with significant dividend increases. Johnson & Johnson NYSE: JNJ, Costco Wh...

2 days ago · marketbeat.com

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manuf...

4 days ago · fool.com

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

President Donald Trump's macroeconomic policies are taking center stage on Wall Street. The 47th U.S. president has decided to implement aggressive tariffs on imported goods from most countries, altho...